Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Long-term longitudinal patterns of patient-reported fatigue after breast cancer: A group-based trajectory analysis journalArticle 2021 A. Di Meglio, J. Havas, M. El-Mouhebb, P. Lapidari, D. Presti, D. Soldato, B. Pistilli, A. Dumas, G. Menvielle, C. Charles, S. Everhard, A.L. Martin, P.H. Cottu, F. Lerebours, C. Coutant, S. Dauchy, S. Delaloge, N. Lin, P. Ganz, A.H. Partridge, F. André, and S. Michiels
New Simplified Screening Method for Postprandial Hypotension in Older People journalArticle 2018 Abbas, R.; Tanguy, A.; Bonnet-Zamponi, D.; Djedid, R.; Lounis, A.; Gaubert-Dahan, M. L.
Incorporating historic information in multi-arm clinical trials for pediatric cancers thesis Abbas, Rachid
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS) journalArticle 2019 Adenis, A.; Bennouna, J.; Etienne, P. L.; Bogart, E.; Francois, E.; Galais, M. P.; Ben Abdelghani, M.; Michel, P.; Metges, J. P.; Dahan, L.; Conroy, T.; Ghiringhelli, F.; Drouillard, A.; El Hajbi, F.; Samalin, E.; Hiret, S.; Delaine-Clisant, S.; Mariette, C.; Penel, N.; Piessen, G.; Le Deley, M. C.
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy journalArticle 2015 Allodji, R. S.; Schwartz, B.; Veres, C.; Haddy, N.; Rubino, C.; Le Deley, M. C.; Labbé, M.; Diop, F.; Jackson, A.; Dayet, F.; Benabdennebi, A.; Llanas, D.; Vu Bezin, J.; Chavaudra, J.; Lefkopoulos, D.; Deutsch, E.; Oberlin, O.; de Vathaire, F.; Diallo, I.
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification journalArticle 2017 Andreiuolo, F.; Le Teuff, G.; Bayar, M. A.; Kilday, J. P.; Pietsch, T.; von Bueren, A. O.; Witt, H.; Korshunov, A.; Modena, P.; Pfister, S. M.; Pagès, M.; Castel, D.; Giangaspero, F.; Chimelli, L.; Varlet, P.; Rutkowski, S.; Frappaz, D.; Massimino, M.; Grundy, R.; Grill, J.
Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification journalArticle 2017 Andreiuolo, F.; Le Teuff, G.; Bayar, M. A.; Kilday, J. P.; Pietsch, T.; von Bueren, A. O.; Witt, H.; Korshunov, A.; Modena, P.; Pfister, S. M.; Pagès, M.; Castel, D.; Giangaspero, F.; Chimelli, L.; Varlet, P.; Rutkowski, S.; Frappaz, D.; Massimino, M.; Grundy, R.; Grill, J.
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study journalArticle 2017 Angevin, E.; Cassier, P. A.; Italiano, A.; Goncalves, A.; Gazzah, A.; Terret, C.; Toulmonde, M.; Gravis, G.; Varga, A.; Parlavecchio, C.; Paci, A.; Poinsignon, V.; Soria, J. C.; Drubay, D.; Hollebecque, A.
Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study journalArticle 2017 Angevin, E.; Cassier, P. A.; Italiano, A.; Goncalves, A.; Gazzah, A.; Terret, C.; Toulmonde, M.; Gravis, G.; Varga, A.; Parlavecchio, C.; Paci, A.; Poinsignon, V.; Soria, J. C.; Drubay, D.; Hollebecque, A.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment journalArticle 2017 Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment journalArticle 2017 Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C.
Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy journalArticle 2017 Annede, P.; Seisen, T.; Klotz, C.; Mazeron, R.; Maroun, P.; Petit, C.; Deutsch, E.; Bossi, A.; Haie-Meder, C.; Chargari, C.; Blanchard, P.
Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy journalArticle 2017 Annede, P.; Seisen, T.; Klotz, C.; Mazeron, R.; Maroun, P.; Petit, C.; Deutsch, E.; Bossi, A.; Haie-Meder, C.; Chargari, C.; Blanchard, P.
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma journalArticle 2016 Anota, A.; Boulin, M.; Dabakuyo-Yonli, S.; Hillon, P.; Cercueil, J. P.; Minello, A.; Jouve, J. L.; Paoletti, X.; Bedenne, L.; Guiu, B.; Bonnetain, F.
Modèles linéaires généralisés mixtes et pseudo-observations comme alternatives à l’analyse de survie Bayésienne pour l’évaluation des thérapies dans les cancers rares thesis Antigny Marine
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting journalArticle 2015 Antoun, S.; Bayar, A.; Ileana, E.; Laplanche, A.; Fizazi, K.; di Palma, M.; Escudier, B.; Albiges, L.; Massard, C.; Loriot, Y.
What''s next in using CT scans to better understand cachexia? journalArticle 2018 Antoun, S.; Rossoni, C.; Lanoy, E.
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer journalArticle 2019 Apolle, R.; Appold, S.; Bijl, H. P.; Blanchard, P.; Bussink, J.; Faivre-Finn, C.; Khalifa, J.; Laprie, A.; Lievens, Y.; Madani, I.; Ruffier, A.; de Ruysscher, D.; van Elmpt, W.; Troost, E. G. C.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial journalArticle 2018 Arnedos, M.; Bayar, M. A.; Cheaib, B.; Scott, V.; Bouakka, I.; Valent, A.; Adam, J.; Leroux-Kozal, V.; Marty, V.; Rapinat, A.; Mazouni, C.; Sarfati, B.; Bieche, I.; Balleyguier, C.; Gentien, D.; Delaloge, S.; Lacroix-Triki, M.; Michiels, S.; Andre, F.
Precision medicine for metastatic breast cancer--limitations and solutions journalArticle 2015 Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F.
Precision medicine for metastatic breast cancer--limitations and solutions journalArticle 2015 Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials journalArticle 2017 Arnold, D.; Lueza, B.; Douillard, J. Y.; Peeters, M.; Lenz, H. J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. P.; Tabernero, J.; Cervantes, A.; Ciardiello, F.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials journalArticle 2017 Arnold, D.; Lueza, B.; Douillard, J. Y.; Peeters, M.; Lenz, H. J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. P.; Tabernero, J.; Cervantes, A.; Ciardiello, F.
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? journalArticle 2017 Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S.
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? journalArticle 2017 Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S.
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion journalArticle 2017 Assayag, M.; Abbas, R.; Chanson, N.; Perozziello, A.; Ducrocq, G.; Alexandra, J. F.; Dossier, A.; Papo, T.; Sacre, K.
Enjeux méthodologiques de la médecine de précision en oncologie journalArticle 2017 Asselain, B.; Paoletti, X.
Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experience journalArticle 2019 Assi, T.; Cavalcanti, A.; Le Cesne, A.; Faron, M.; Honart, J. F.; Hadiji, A.; Camuzard, O.; Ibrahim, T.; LePechoux, C.; Mir, O.; Dumont, S.; Terrier, P.; Adam, J.; Honore, C.
Estimating causal effects of time-dependent exposures on a binary endpoint in a high-dimensional setting journalArticle 2018 Asvatourian, V.; Coutzac, C.; Chaput, N.; Robert, C.; Michiels, S.; Lanoy, E.
Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study journalArticle 2017 Atlan, P.; Bayar, M. A.; Lanoy, E.; Besse, B.; Planchard, D.; Ramon, J.; Raynard, B.; Antoun, S.
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study journalArticle 2018 Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B.
A Novel Spectroscopically Determined Pharmacodynamic Biomarker for Skin Toxicity in Cancer Patients Treated with Targeted Agents journalArticle 2017 Azan, A.; Caspers, P. J.; Bakker Schut, T. C.; Roy, S.; Boutros, C.; Mateus, C.; Routier, E.; Besse, B.; Planchard, D.; Seck, A.; Kamsu Kom, N.; Tomasic, G.; Koljenovic, S.; Noordhoek Hegt, V.; Texier, M.; Lanoy, E.; Eggermont, A. M.; Paci, A.; Robert, C.; Puppels, G. J.; Mir, L. M.
Clinical outcomes after interstitial brachytherapy for early-stage nasal squamous cell carcinoma journalArticle 2017 Bacorro, W.; Escande, A.; Temam, S.; Dumas, I.; Routier, E.; Gensse, M. C.; Blanchard, P.; Janot, F.; Mateus, C.; Tao, Y.; Robert, C.; Deutsch, E.; Haie-Meder, C.; Chargari, C.
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial journalArticle 2018 Bahig, H.; Yuan, Y.; Mohamed, A. S. R.; Brock, K. K.; Ng, S. P.; Wang, J.; Ding, Y.; Hutcheson, K.; McCulloch, M.; Balter, P. A.; Lai, S. Y.; Al-Mamgani, A.; Sonke, J. J.; van der Heide, U. A.; Nutting, C.; Li, X. A.; Robbins, J.; Awan, M.; Karam, I.; Newbold, K.; Harrington, K.; Oelfke, U.; Bhide, S.; Philippens, M. E. P.; Terhaard, C. H. J.; McPartlin, A. J.; Blanchard, P.; Garden, A. S.; Rosenthal, D. I.; Gunn, G. B.; Phan, J.; Cazoulat, G.; Aristophanous, M.; McSpadden, K. K.; Garcia, J. A.; van den Berg, C. A. T.; Raaijmakers, C. P. J.; Kerkmeijer, L.; Doornaert, P.; Blinde, S.; Frank, S. J.; Fuller, C. D.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2018 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2017 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2017 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients journalArticle 2016 Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F.
Percutaneous Thermal Ablation of Breast Cancer Metastases in Oligometastatic Patients journalArticle 2016 Barral, M.; Auperin, A.; Hakime, A.; Cartier, V.; Tacher, V.; Otmezguine, Y.; Tselikas, L.; de Baere, T.; Deschamps, F.
Revisiting the definition of dose-limiting toxicities in paediatric oncology phase I clinical trials: An analysis from the Innovative Therapies for Children with Cancer Consortium journalArticle 2017 Bautista, F.; Moreno, L.; Marshall, L.; Pearson, A. D. J.; Geoerger, B.; Paoletti, X.